"Epic Care CyberKnife is a radiation oncology center located in Walnut Creek, CA. We provide the East Bay Area oncology care with our innovative CyberKnife system that combines cutting-edge technology with a highly experienced physician, Dr. Gautam Prasad, MD, PhD, who is well-recognized in the field of radiation oncology. We provide our patients with advanced cancer treatments designed specifically for their unique cases, including prostate cancer, lung cancer, & breast cancer."

During the past decade, Epic Care Cyberknife Center conducted 49 clinical trials. In the 10-year time frame, 49 clinical trials started and 5 clinical trials were completed, i.e. on average, 10.2% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 5 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Epic Care Cyberknife Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 17 trials, followed by "National Cancer Institute (NCI)" with 17 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "NRG Oncology" with 8 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Epic Care Cyberknife Center" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Epic Care Cyberknife Center" are "Invasive Breast Carcinoma" (8 trials), "Metastatic Malignant Neoplasm in the Brain" (6 trials), "Stage IIIA Breast Cancer" (6 trials), "Stage II Breast Cancer" (5 trials) and "Stage IIA Breast Cancer" (4 trials). Many other conditions were trialed in "Epic Care Cyberknife Center" in a lesser frequency.

Most popular intervention types in "Epic Care Cyberknife Center" are "Drug" (39 trials), "Other" (33 trials), "Biological" (19 trials), "Procedure" (18 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Questionnaire Administration" (13 trials), "Computed Tomography" (9 trials), "Laboratory Biomarker Analysis" (8 trials) and "Nivolumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Epic Care Cyberknife Center" are 49 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Epic Care Cyberknife Center". undefined are not yet recruiting, 23 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Epic Care Cyberknife Center, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Epic Care Cyberknife Center, 0 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".